A new approach to assessing occupational exposure to antineoplastic drugs in hospital environments

Author:

Dugheri Stefano12,Bonari Alessandro2,Pompilio Ilenia2,Boccalon Pierpaolo3,Mucci Nicola2,Arcangeli Giulio32

Affiliation:

1. Careggi University Hospital, Medicina del Lavoro – Laboratorio di Igiene e Tossicologia Industriale, Florence , Italy

2. University of Florence, Dipartimento di Medicina Sperimentale e Clinica, Florence , Italy

3. Careggi University Hospital, Medicina del Lavoro - Laboratorio di Igiene e Tossicologia Industriale, Florence , Italy

Abstract

Abstract Cytotoxic antineoplastic drugs (ADs) pose occupational risk and therefore require safe handling practices. We created, optimised, and validated an innovative monitoring protocol for simultaneously assessing 21 ADs in the healthcare environment, and also proposed surface exposure levels (SELs) to facilitate the interpretation of monitoring results, as there are currently no occupational exposure limits for ADs. The environmental AD monitoring data were collected in nine Italian hospitals between 2008 and 2017 and include 74,565 measurements in 4,814 wipe samples. Excellent overall recovery and sensitivity of the analytical methods along with innovative desorption automation make this protocol useful for routine monitoring. AD contamination was found in 3,081 measurements, confirming potential exposure in healthcare workers. Samples taken at the beginning and the end of work shifts, allowed to calculate 75th and 90th percentile values for each ADs both in preparation and administration units and we created a traffic-light colour-coding system to facilitate interpretation of the findings. The introduction of SELs will provide a solid basis for improving occupational safety and focusing on contamination control.

Publisher

Walter de Gruyter GmbH

Subject

Public Health, Environmental and Occupational Health,Toxicology

Reference46 articles.

1. 1. World Cancer Research Fund International (WCRF). Worldwide data [displayed 1 August 2018]. Available at http://www.wcrf.org/int/cancer-facts-figures/worldwide-data

2. 2. Transparency Market Research. Anti-cancer drugs market - global industry analysis, size, share, growth, trends, and forecast 2016 - 2024. In: Global anti-cancer drugs market: competitive landscape and region-wise outlook [displayed 1 August 2018]. Available at https://www.transparencymarketresearch.com/anticancer-drugs-market.html

3. 3. Report Buyer Ltd. Market research and forecast of antineoplastic drugs in China 2016-2021. In: Smmary [displayed 1 August 2018]. Available at https://www.reportbuyer.com/product/4696059/market-research-andforecast-of-antineoplastic-drugs-in-china-2016-2021.html

4. 4. Zion Market Research. Cancer drugs market by therapy (immunotherapy, targeted therapy, chemotherapy, hormone therapy and others) for breast cancer, blood cancer, gastrointestinal cancer, prostate cancer, skin cancer, lung cancer and other cancer: global industry perspective, comprehensive analysis and forecast, 2015-2021. Florida, United States; 2016. [displayed 1 August 2018]. Available at https://www.zionmarketresearch.com/news/global-cancerdrugs-market

5. 5. Allied Market Research. Oncology/cancer drugs market by therapeutic modalities (chemotherapy, targeted therapy, immunotherapy, hormonal), cancer types (blood, breast, gastrointestinal, prostate, skin, respiratory/lung cancer) - Global opportunity analysis and industry forecast, 2013-2020. Pune, India; 2015. In: Global Oncology/Cancer Drugs Market [displayed 1 August 2018]. Available at https://www.alliedmarketresearch.com/oncology-cancer-drugs-market

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3